- Home
- » e-Newsletters
Roche halts shipments of Tamiflu
Infection Control Monitor, October 28, 2005
A drug manufacturer has temporarily halted shipments of Tamiflu to ensure adequate supplies will be used to treat conventional flu cases this season, reports The New York Times.
Roche, which is based in Switzerland, believes some companies are creating their own stockpiles to treat employees in the event of a bird flu pandemic.
Many countries are scrambling to stockpile Tamiflu, and Roche has been unable to meet the demands. Last week the company said it is considering allowing other companies to make the drug.
Tamiflu, also known as oseltamivir, can reduce the duration of the flu or, in some cases, prevent it. It is unclear how well it will work against bird flu.
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- HealthDataInsights posts new issues for medical necessity claims
- Running an effective peer review committee meeting
- Sneak Peek: Effort underway to establish caseload benchmarks
- New FAQ posted on storing laryngoscope blades
- Q&A: Incidental disclosures and patient privacy
- Tip: Perform your own internal investigation prior to government audit
- What does case-mix index mean to you?
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Tip: Correctly code bilateral pain management procedures
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Documentation and coding for toxic metabolic encephalopathy
- Guidance and tact key to compliant, effective physician queries
- Searched